Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial

Faster, Cleaner, Better.

Minerva Neuroscie (NERV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2020	12-2019	12-2018	12-2017	12-2016
Cash Flows From Operating Activities
Net Income	1,941	-72,184	-50,171	-31,523	-31,045
Depreciation Amortization	89	-603	-64	32	467
Income taxes - deferred	0	-2,254	N/A	-9,376	N/A
Accounts payable and accrued liabilities	-1,321	517	364	-33	108
Other Working Capital	-45,556	3,435	111	38,927	1,320
Other Operating Activity	11,026	27,656	7,819	5,066	3,463
Operating Cash Flow	$-33,822	$-43,432	$-41,942	$3,093	$-25,688

Cash Flows From Investing Activities
Change In Deposits	24,528	14,085	69,490	-107,136	17,818
PPE Investments	N/A	N/A	N/A	-52	N/A
Investing Cash Flow	$24,528	$14,085	$69,490	$-107,188	$17,818

Cash Flows From Financing Activities
Debt Repayment	N/A	N/A	-4,001	-4,939	-1,571
Common Stock Issued	13,694	525	656	55,050	81,969
Other Financing Activity	-456	0	0	-2,944	-3,832
Financing Cash Flow	$13,238	$525	$-3,345	$47,167	$76,566

Beginning Cash Position	21,513	50,335	26,132	83,061	14,284
End Cash Position	25,457	21,513	50,335	26,132	82,981
Net Cash Flow	$3,944	$-28,822	$24,203	$-56,929	$68,697

Free Cash Flow
Operating Cash Flow	-33,822	-43,432	-41,942	3,093	-25,688
Capital Expenditure	N/A	N/A	N/A	-52	N/A
Free Cash Flow	-33,822	-43,432	-41,942	3,041	-25,688